• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Multiforme skin lesions in Yekatit 12 Hospital, 1976-1994.

作者信息

Gessesse B, Mulugeta E

机构信息

Department of Internal Medicine, Yekatit 12 Hospital, Addis Ababa.

出版信息

Ethiop Med J. 2000 Jan;38(1):43-7.

PMID:11144879
Abstract

Because the number of cases of multiforme skin lesions encountered in the medical department of Yekatit 12 Hospital has increased in recent years, we conducted a retrospective study to identify the likely precipitating factors and the possible relationship of these with HIV infection. Forty-seven patients with Multiforme Skin Lesions (29 males, 18 females) were admitted between 1976 and January 1994, of whom 43 (92%) were admitted in the past 5 years. Most patients were aged 15-49 years. Thirty patients (64%) were discharged improved and 14 (30%) expired in hospital. The outcome of 3 patients are not known. The charts of only 16 patients could be retrieved for review. Fifteen of these (94%) gave a history of intake of streptomycin, isoniazed and thiacetazone prior to developing the skin manifestation. The anti-TB medications were discontinued initially; 14 patients were restarted on STM, INH and ethambutol without recurrence of the rash. All but 1 were discharged improved. HIV screening tests were done on 24 patients with multiforme skin lesion of whom 21 (88%) were seropositive. Our study suggested that the adverse effects of thiacetazone are increased in HIV associated tuberculous patients. We recommend that further studies be conducted in HIV seropositive and seronegative patients.

摘要

相似文献

1
Multiforme skin lesions in Yekatit 12 Hospital, 1976-1994.
Ethiop Med J. 2000 Jan;38(1):43-7.
2
HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.喀麦隆雅温得接受不含氨硫脲抗结核治疗的成年肺结核患者的HIV血清流行率及皮肤不良反应发生率
East Afr Med J. 1997 Aug;74(8):474-7.
3
Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania.坦桑尼亚艾滋病毒感染患者在结核病治疗期间发生的严重皮肤过敏反应
Trop Geogr Med. 1992 Oct;44(4):308-11.
4
Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis.在接受抗结核治疗的HIV-1血清阳性患者中,因氨硫脲引起的皮肤过敏反应。
Lancet. 1991 Mar 16;337(8742):627-30. doi: 10.1016/0140-6736(91)92447-a.
5
Two years review of cutaneous adverse drug reaction from first line anti-tuberculous drugs.一线抗结核药物引起的皮肤药物不良反应的两年回顾
Med J Malaysia. 2007 Jun;62(2):143-6.
6
[Tuberculosis in compromised hosts].[免疫功能低下宿主中的结核病]
Kekkaku. 2003 Nov;78(11):717-22.
7
[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].[耐异烟肼或耐利福平结核病的特征及治疗结果]
Kekkaku. 2003 Oct;78(10):611-7.
8
Tolerability of anti-tuberculosis treatment and HIV serostatus.抗结核治疗的耐受性与HIV血清学状态
Int J Tuberc Lung Dis. 2007 Nov;11(11):1203-9.
9
Life-threatening cutaneous reactions to thiacetazone-containing antituberculosis treatment in Kumasi, Ghana.加纳库马西地区含硫代乙酰胺的抗结核治疗引发的危及生命的皮肤反应。
West Afr J Med. 1999 Oct-Dec;18(4):249-53.
10
[HIV seroprevalence in patients with tuberculosis].
Kekkaku. 2001 Nov;76(11):679-84.